A. Durrbach

A. Scherer, C. Berthier, A. Durrbach, 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Laparoscopic sleeve gastrectomy for morbid obesity in renal transplantation candidates: a matched case–control study

S. Beaudreuil, A. Durrbach, P. Lainas, 2020, Transplant international : official journal of the European Society for Organ Transplantation.

Reduction of Extended‐Release Tacrolimus Dose in Low‐Immunological‐Risk Kidney Transplant Recipients Increases Risk of Rejection and Appearance of Donor‐Specific Antibodies: A Randomized Study

L. Rostaing, E. Thervet, N. Kamar, 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Should kidney tubular markers be adjusted for urine creatinine? The example of urinary cystatin C

M. Devanlay, A. Durrbach, S. Loric, 2009, Clinical chemistry and laboratory medicine.

Temporal trends in living kidney donation in France between 2007 and 2017.

P. Rieu, L. Rostaing, N. Kamar, 2019, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Protein A immunoadsorption cannot significantly remove the soluble receptor of urokinase from sera of patients with recurrent focal segmental glomerulosclerosis.

A. Vazquez, H. François, S. Beaudreuil, 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Belatacept in renal transplant recipient with mild immunologic risk factor: A pilot prospective study (BELACOR)

L. Salomon, Thomas Robert, A. Moktefi, 2019, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Genotype vanA Phenotype Associated with a Expressing a VanD-Like faecium Enterococcus Vancomycin-Resistant First Nosocomial Outbreak of

P. Nordmann, T. Naas, R. Snanoudj, 2005 .

Combined Liver-Kidney Transplantation With Preformed Anti–human Leukocyte Antigen Donor-Specific Antibodies

J. Dumortier, N. Kamar, P. Gatault, 2020, Kidney international reports.

A Randomized Prospective Study Comparing Anti–T-Lymphocyte Igs to Basiliximab in Highly Sensitized Kidney Transplant Patients

N. Kamar, A. Durrbach, É. Cassuto, 2020, Kidney international reports.

Transplantation: Pre-emptive kidney transplantation—perfect, but when?

B. Charpentier, A. Durrbach, 2011, Nature Reviews Nephrology.

Impact of polyclonal antithymocyte globulins on kidney transplant outcomes in real-life: a propensity score analysis

P. Rieu, A. Heng, L. Frimat, 2019 .

[Prospective study of harvest-to-transplant time: proposed organization].

J. Duranteau, A. Durrbach, G. Benôit, 2003, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

IgA nephropathy associated with ankylosing spondylitis is not controlled by infliximab therapy.

X. Mariette, C. Frangié, H. François, 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Prospective Comparison of the Use of Sirolimus and Cyclosporine in Recipients of a Kidney From an Expanded Criteria Donor

L. Rostaing, E. Thervet, C. Pouteil‐Noble, 2008, Transplantation.

CD57+ CD4 T Cells Underlie Belatacept‐Resistant Allograft Rejection

A. Kirk, G. Tharp, S. Bosinger, 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Antibodies, a Potent Tool to Target Genes into Designated Cells and Tissues

A. Durrbach, F. Hirsch, O. Déas, 2004 .

Complement modulation in solid-organ transplantation.

H. François, S. Beaudreuil, A. Durrbach, 2014, Transplantation reviews.

Do unconventional myosins exert functions in dynamics of membrane compartments?

A. Durrbach, D. Louvard, E. Coudrier, 1992, FEBS letters.

A Phase III Study of Belatacept Versus Cyclosporine in Kidney Transplants from Extended Criteria Donors (BENEFIT‐EXT Study)

J. Campistol, J. O. Pestana, F. Vincenti, 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

New aspect of immunosuppressive treatment in liver transplantation. How could you induce tolerance in liver transplantation?

D. Samuel, N. Rouas-Freiss, S. Beaudreuil, 2007, Transplant immunology.

Co-signals in organ transplantation

H. François, S. Beaudreuil, B. Charpentier, 2010, Current opinion in organ transplantation.

S. Negrini, A. Durrbach, L. Becquemont, 2014, Therapie.

SYK Inhibition Induces Apoptosis in Germinal Center-Like B Cells by Modulating the Antiapoptotic Protein Myeloid Cell Leukemia-1, Affecting B-Cell Activation and Antibody Production

A. Vazquez, A. Durrbach, O. Thaunat, 2018, Front. Immunol..

SLCO1B1 genetic polymorphism influences mycophenolic acid tolerance in renal transplant recipients.

M. Fromm, B. Charpentier, A. Durrbach, 2010, Pharmacogenomics.

Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paper.

P. Chanson, J. Soria, D. Samuel, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Efficacy and tolerance of immune checkpoint inhibitors in transplant patients with cancer: A systematic review

A. Durrbach, M. Zaidan, Thibaut d'Izarny-Gargas, 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

The proliferation of belatacept‐resistant T cells requires early IFNα pathway activation

A. Durrbach, C. Desterke, B. Vanhove, 2021, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Low immunogenicity of quadrivalent meningococcal vaccines in solid organ transplant recipients

D. Samuel, H. François, A. Durrbach, 2015, Transplant infectious disease : an official journal of the Transplantation Society.

Actinobacillus actinomycetemcomitans endocarditis: an unusual cause of rapidly progressive glomerulonephritis

M. Ghigna, H. François, A. Durrbach, 2010 .

Surgical prevention and management of vascular complications of kidney transplantation

B. Charpentier, A. Durrbach, D. Bedretdinova, 2012, Transplant international : official journal of the European Society for Organ Transplantation.

Incidence of cytomegalovirus infection in seropositive kidney transplant recipients treated with everolimus: A randomized, open‐label, multicenter phase 4 trial

N. Kamar, T. Bachelet, R. Thiébaut, 2022, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Efficacy and Safety of Intra-gastric Balloon Placement in Dialyzed Patients Awaiting Kidney Transplantation

F. Iglicki, S. Ledoux, S. Beaudreuil, 2018, Obesity Surgery.

Effect of a Proteasome Inhibitor Plus Steroids on HLA Antibodies in Sensitized Patients Awaiting a Renal Transplant

R. Gauthé, C. Suberbielle, H. François, 2014, Transplantation.

Absence of CD4CD25 regulatory T cell expansion in renal transplanted patients treated in vivo with Belatacept mediated CD28-CD80/86 blockade.

S. Beaudreuil, B. Charpentier, A. Durrbach, 2007, Transplant immunology.

Longitudinal evaluation of the impact of immunosuppressive regimen on immune responses to COVID-19 vaccination in kidney transplant recipients

P. Grimbert, A. Durrbach, Y. Lévy, 2022, Frontiers in Medicine.

Impact of DSA and immunosuppression minimization on rejection, graft, and patient survival after simultaneous liver–kidney transplantation

F. Saliba, A. Durrbach, A. Coilly, 2022, Frontiers in Medicine.

Five-year safety and efficacy of belatacept in renal transplantation.

P. Friend, P. Halloran, J. Klempnauer, 2010, Journal of the American Society of Nephrology : JASN.

[Use of new non-nephrotoxic immunosuppressive drugs in kidney transplantation, especially after ischemia-reperfusion injury].

H. François, S. Beaudreuil, B. Charpentier, 2011, Bulletin de l'Academie nationale de medecine.

Truncated Brush Border Myosin I Affects Membrane Traffic in Polarized Epithelial Cells

G. Raposo, A. Durrbach, D. Louvard, 2000, Traffic.

Kidney transplantation in patients with systemic sclerosis: a nationwide multicentre study

A. Heng, N. Kamar, A. Durrbach, 2017, Transplant international : official journal of the European Society for Organ Transplantation.

Concise review: Combining human leukocyte antigen G and mesenchymal stem cells for immunosuppressant biotherapy

N. Rouas-Freiss, E. Carosella, A. Durrbach, 2013, Stem cells.

CD3+CD4low and CD3+CD8low are induced by HLA-G: novel human peripheral blood suppressor T-cell subsets involved in transplant acceptance.

N. Rouas-Freiss, E. Carosella, C. Créput, 2007, Blood.

Investigation of new biomarkers of kidney injury in renal transplant recipients undergoing graft biopsy

T. Joos, O. Poetz, A. Durrbach, 2021, Clinical transplantation.

Investigation of novel biomarkers of drug-induced kidney injury in renal transplant recipients undergoing graft biopsy

T. Joos, O. Poetz, A. Durrbach, 2019 .

The Puzzle of Immunosuppressive Drugs

A. Durrbach, J. Oniszczuk, Manon Dekeyser, 2021, OBM Transplantation.

Optimization of de novo belatacept‐based immunosuppression administered to renal transplant recipients

A. Kirk, E. Woodle, David A Hildeman, 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

The anti-CD40 auto-antibody: a biomarker or a factor for the permeability of recurrent focal segmental glomerulosclerosis?

S. Beaudreuil, A. Durrbach, H. Lorenzo, 2015, Annals of translational medicine.

Processing of filamentous bacteriophage virions in antigen-presenting cells targets both HLA class I and class II peptide loading compartments.

D. Piatier‐Tonneau, J. Guardiola, R. Perham, 2003, DNA and cell biology.

Cannabinoid receptor 1 is a major mediator of renal fibrosis.

C. Ledent, A. Vazquez, S. Grassin-Delyle, 2015, Kidney international.

Kidney transplantation: into the future with belatacept

H. François, B. Charpentier, A. Durrbach, 2012 .

[Belatacept, a new original molecule, immunosuppressive, in organ transplantation].

S. Beaudreuil, B. Charpentier, A. Durrbach, 2006, Medecine sciences : M/S.

Human leukocyte antigen-G (HLA-G) expression in biliary epithelial cells is associated with allograft acceptance in liver-kidney transplantation.

J. Dausset, D. Samuel, N. Rouas-Freiss, 2003, Journal of hepatology.

Liver–kidney recipients with chronic viral hepatitis C treated with interferon‐alpha

D. Samuel, B. Roche, B. Charpentier, 2012, Transplant International.

Immunological Strategies Targeting B Cells in Organ Grafting

R. Snanoudj, S. Beaudreuil, B. Charpentier, 2005, Transplantation.

B7-1 Blockade Does Not Improve Post-Transplant Nephrotic Syndrome Caused by Recurrent FSGS.

G. Canaud, F. Terzi, G. Deschênes, 2016, Journal of the American Society of Nephrology : JASN.

Pre‐transplant end‐stage renal disease‐related immune risk profile in kidney transplant recipients predicts post‐transplant infections

P. Rieu, L. Frimat, P. Saas, 2016, Transplant infectious disease : an official journal of the Transplantation Society.

Long-Lasting Inhibitory Effects of Fetal Liver Mesenchymal Stem Cells on T-Lymphocyte Proliferation

A. Durrbach, M. Giuliani, B. Azzarone, 2011, PloS one.

Primary brain lymphomas after kidney transplantation: presentation and outcome

C. Lacroix, M. Mamzer-Bruneel, V. Leblond, 2003, Transplantation.

Very early steroid withdrawal in simultaneous pancreas-kidney transplants.

J. Duranteau, S. Beaudreuil, B. Charpentier, 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Single-center experience with cyclosporine therapy for kidney transplantation: analysis of a twenty-year period in 1200 patients.

R. Snanoudj, S. Beaudreuil, B. Charpentier, 2004, Transplantation proceedings.

Parvovirus B19‐induced anemia in renal transplantation: a role for rHuEPO in resistance to classical treatment

R. Snanoudj, B. Charpentier, N. Arzouk, 2006, Transplant International.

Recovery from Pure Red Cell Aplasia Caused by Anti‐Erythropoietin Antibodies After Kidney Transplantation

N. Casadevall, R. Snanoudj, S. Beaudreuil, 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

HLA-G in organ transplantation: towards clinical applications

V. Pistoia, D. Delgado, A. Durrbach, 2011, Cellular and Molecular Life Sciences.

Everolimus de novo in liver transplantation.

Y. Calmus, A. Durrbach, 2009, Gastroenterologie clinique et biologique.

The role of replicative senescence in chronic allograft nephropathy.

P. Bedossa, B. Charpentier, A. Durrbach, 2003, Human pathology.

Glomerular Lesions in Patients With Sickle Cell Disease

O. Lambotte, P. Lang, P. Niaudet, 2010, Medicine.

Long-term health-related quality of life outcomes of adults with pediatric onset of frequently relapsing or steroid-dependent nephrotic syndrome

Z. Massy, K. Dahan, E. Daugas, 2021, Journal of Nephrology.

Prevalence of renal cell carcinoma in patients with autosomal dominant polycystic kidney disease and chronic renal failure.

B. Charpentier, A. Durrbach, G. Benôit, 2009, Urology.

Detection of HLA-G in serum and graft biopsy associated with fewer acute rejections following combined liver-kidney transplantation: possible implications for monitoring patients.

N. Rouas-Freiss, E. Carosella, C. Créput, 2003, Human immunology.

Immune reconstitution with two different rabbit polyclonal anti-thymocytes globulins.

P. Rieu, A. Heng, L. Frimat, 2017, Transplant Immunology.

Pretransplant thymic function predicts acute rejection in antithymocyte globulin-treated renal transplant recipients.

P. Rieu, A. Heng, L. Frimat, 2016, Kidney international.

Cord blood CD133 cells define an OV6-positive population that can be differentiated in vitro into engraftable bipotent hepatic progenitors.

R. Marchese, E. Brunetti, A. Durrbach, 2011, Stem cells and development.

Transfer of ADAMTS13 antibody-mediated thrombotic thrombocytopenic purpura via kidney transplantation

É. Azoulay, A. Durrbach, P. Coppo, 2019, Haematologica.

Absence of circadian variations in urine cystatin C allows its use on urinary samples.

A. Durrbach, S. Loric, M. Conti, 2005, Clinical chemistry.

Incidence of Renal and Liver Rejection and Patient Survival Rate Following Combined Liver and Kidney Transplantation

D. Samuel, H. Bismuth, C. Créput, 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Impact of targeted hypothermia in expanded-criteria organ donors on recipient kidney-graft function: study protocol for a multicentre randomised controlled trial (HYPOREME)

K. Asehnoune, L. Rostaing, A. Heng, 2022, BMJ Open.

Impact of VKORC1 Haplotypes on Long-Term Graft Function in Kidney Transplantation

B. Charpentier, A. Durrbach, C. Verstuyft, 2008, Transplantation.

Development and validation of an LC/MS/MS assay for mycophenolic acid in human peripheral blood mononuclear cells.

A. Durrbach, A. Pruvost, V. Furlan, 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Three‐Year Outcomes From BENEFIT‐EXT: A Phase III Study of Belatacept Versus Cyclosporine in Recipients of Extended Criteria Donor Kidneys

M. Schnitzler, R. Manfro, N. Kamar, 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

BELATACEPT VS CYCLOSPORINE IN ECD KIDNEY TRANSPLANTS: TWO-YEAR OUTCOMES FROM THE BENEFIT-EXT STUDY: 1394

Y. Vanrenterghem, F. Vincenti, C. Larsen, 2010 .

Genotype-phenotype correlation in primary hyperoxaluria type 1: the p.Gly170Arg AGXT mutation is associated with a better outcome.

D. Abramowicz, M. Rolland, A. Schott, 2010, Kidney international.

Soluble HLA-G and HLA-G1 expressing antigen-presenting cells inhibit T-cell alloproliferation through ILT-2/ILT-4/FasL-mediated pathways.

N. Rouas-Freiss, E. Carosella, A. Durrbach, 2007, Human immunology.

Progressive Increase of Anxiety and Depression in Patients Waiting for a Kidney Transplantation

E. Corruble, B. Falissard, P. Lang, 2010, Behavioral medicine.

Fumagillin for Treatment of Intestinal Microsporidiosis in Renal Transplant Recipients

M. Delahousse, D. Glotz, A. Durrbach, 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Interaction between tacrolimus and fumagillin in two kidney transplant recipients.

R. Snanoudj, N. Arzouk, A. Durrbach, 2006, Transplantation.

IMPact of the COVID-19 epidemic on the moRTAlity of kidney transplant recipients and candidates in a French Nationwide registry sTudy (IMPORTANT)

J. Dumortier, A. Heng, N. Kamar, 2020, Kidney International.

Dendritic Cells Secrete the Immunosuppressive HLA-G Molecule upon CTLA4-Ig Treatment: Implication in Human Renal Transplant Acceptance1

N. Rouas-Freiss, E. Carosella, B. Charpentier, 2009, The Journal of Immunology.

CTLA 4-Ig Treatment : Implication in Human Immunosuppressive HLA-G Molecule upon Dendritic Cells Secrete the and

N. Rouas-Freiss, E. Carosella, B. Charpentier, 2009 .

Evidence to Support the Role of HLA-G5 in Allograft Acceptance through Induction of Immunosuppressive/ Regulatory T Cells1

N. Rouas-Freiss, E. Carosella, A. Durrbach, 2006, The Journal of Immunology.

Alloreactive CD4+ and CD8+ T cells express the immunotolerant HLA‐G molecule in mixed lymphocyte reactions: in vivo implications in transplanted patients

J. Dausset, N. Rouas-Freiss, E. Carosella, 2004, European journal of immunology.

Rituximab in anti-GBM disease: A retrospective study of 8 patients.

N. Anguel, H. François, A. Durrbach, 2015, Journal of autoimmunity.

Efficacy and safety of the H1N1 monovalent vaccine in renal-transplant recipients and dialysis patients

A. Seidowsky, H. François, S. Beaudreuil, 2011, Human vaccines.

Human mesenchymal stem cells derived from induced pluripotent stem cells down-regulate NK-cell cytolytic machinery.

S. Chouaib, A. Bennaceur-Griscelli, N. Oudrhiri, 2011, Blood.

Advances in immunosuppression for renal transplantation

H. François, S. Beaudreuil, B. Charpentier, 2010, Nature Reviews Nephrology.

Human POMp75 is identified as the pro-oncoprotein TLS/FUS: both POMp75 and POMp100 DNA homologous pairing activities are associated to cell proliferation

A. Durrbach, F. Delacôte, B. Lopez, 1999, Oncogene.

Post-transplantation lymphoproliferative disorder after kidney transplantation: report of a nationwide French registry and the development of a new prognostic score.

R. Porcher, A. Heng, O. Toupance, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Epstein-Barr Virus Infection and Altered Control of Apoptotic Pathways in Posttransplant Lymphoproliferative Disorders

D. Samuel, M. Paulli, P. Schüffler, 2012, Pathobiology.

Lymphocyte Cell-Cycle Inhibition by HLA-G Is Mediated by Phosphatase SHP-2 and Acts on the mTOR Pathway

B. Charpentier, A. Durrbach, M. Giuliani, 2011, PloS one.

Persistence of Yellow Fever Vaccine–Induced Antibodies After Solid Organ Transplantation

D. Samuel, M. Mamzer-Bruneel, H. François, 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Belatacept-Based Regimens Are Associated With Improved Cardiovascular and Metabolic Risk Factors Compared With Cyclosporine in Kidney Transplant Recipients (BENEFIT and BENEFIT-EXT Studies)

H. Neumayer, P. Lang, J. Campistol, 2011, Transplantation.

Urodynamic testing predicts long‐term urological complications following simultaneous pancreas–kidney transplantation

B. Charpentier, A. Durrbach, G. Benôit, 2003, Clinical transplantation.

Fibrosis Progression According to Epithelial‐Mesenchymal Transition Profile: A Randomized Trial of Everolimus Versus CsA

L. Rostaing, S. Quéré, A. Durrbach, 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Report of depressive symptoms on waiting list and mortality after liver and kidney transplantation: a prospective cohort study

E. Corruble, D. Samuel, B. Falissard, 2011, BMC psychiatry.

Maturity onset diabetes of the young: clinical characteristics and outcome after kidney and pancreas transplantation in MODY3 and RCAD patients: a single center experience

C. Bellanné-Chantelot, H. François, S. Beaudreuil, 2012, Transplant international : official journal of the European Society for Organ Transplantation.

Reversibility of Acquired Amyloid Polyneuropathy After Liver Retransplantation

C. Lacroix, D. Samuel, P. Lozeron, 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Changes in renal function in patients with familial amyloid polyneuropathy treated with orthotopic liver transplantation.

D. Samuel, P. Bedossa, H. Bismuth, 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[HLA-G: immunoregulatory molecule involved in allograft acceptance].

N. Rouas-Freiss, E. Carosella, C. Créput, 2003, Nephrologie.

Peripheral blood T cells generated after allogeneic bone marrow transplantation: lower levels of bcl-2 protein and enhanced sensitivity to spontaneous and CD95-mediated apoptosis in vitro. Abrogation of the apoptotic phenotype coincides with the recovery of normal naive/primed T-cell profiles.

B. Charpentier, A. Durrbach, J. Vernant, 1999, Blood.

Tolerogenic Functions of Human Leukocyte Antigen G: From Pregnancy to Organ and Cell Transplantation

N. Rouas-Freiss, E. Carosella, A. Durrbach, 2007, Transplantation.

Is COVID-19 infection more severe in kidney transplant recipients?

N. Kamar, L. Frimat, P. Grimbert, 2020, American Journal of Transplantation.

Erdheim-Chester disease in childhood: a challenging diagnosis and treatment.

A. Durrbach, F. Charlotte, J. Haroche, 2009, Journal of pediatric hematology/oncology.

A French Cohort Study of Kidney Retransplantation after Post-Transplant Lymphoproliferative Disorders.

A. Heng, N. Kamar, L. Frimat, 2017, Clinical journal of the American Society of Nephrology : CJASN.

Immunosuppression and Graft Rejection in Living-related HLA-identical Renal Transplantation: The RADOVFULL Study

L. Rostaing, L. Frimat, A. Durrbach, 2020, Transplantation.

Outcomes at 7 years post‐transplant in black vs nonblack kidney transplant recipients administered belatacept or cyclosporine in BENEFIT and BENEFIT‐EXT

L. Rostaing, M. Abouljoud, F. Vincenti, 2018, Clinical transplantation.

Ten‐year outcomes in a randomized phase II study of kidney transplant recipients administered belatacept 4‐weekly or 8‐weekly

H. Meier‐Kriesche, F. Vincenti, C. Larsen, 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Long‐Term Outcomes in Belatacept‐ Versus Cyclosporine‐Treated Recipients of Extended Criteria Donor Kidneys: Final Results From BENEFIT‐EXT, a Phase III Randomized Study

L. Rostaing, H. Meier‐Kriesche, A. Durrbach, 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Vaccination in adults with auto-immune disease and/or drug related immune deficiency: results of the GEVACCIM Delphi survey.

J. Pouchot, X. Mariette, E. Hachulla, 2009, Vaccine.

Human Fetal Liver Mesenchymal Stem Cell-Derived Exosomes Impair Natural Killer Cell Function.

E. Oberlin, A. Durrbach, F. Herr, 2019, Stem cells and development.

Cytokine expression in peripheral CD57(+) T cells from tolerant renal allograft recipients.

B. Charpentier, A. Durrbach, C. Legendre, 2000, Transplantation proceedings.

Comparison of the AN69ST Membrane versus Citrate-Enriched Dialysate on Clotting Events during Hemodialysis without Systemic Anticoagulation

A. Rachas, H. François, S. Beaudreuil, 2017, Blood Purification.

New clinical forms of hereditary apoA-I amyloidosis entail both glomerular and retinal amyloidosis.

N. Rioux-Leclercq, D. Samuel, F. Paraf, 2020, Kidney international.

Long‐term results (10 years) of a prospective trial comparing Lo‐tact‐1 monoclonal antibody and anti‐thymocyte globulin induction therapy in kidney transplantation

H. Bazin, S. Beaudreuil, B. Charpentier, 2006, Transplant international : official journal of the European Society for Organ Transplantation.

When Immunity Kills: The Lessons of SARS-CoV-2 Outbreak

F. Mami-Chouaib, Stéphanie Corgnac, A. Durrbach, 2021, Frontiers in Immunology.

Tissue engineering for penile surgery: comparative study of noncellular and cell-seeded synthetic grafts for tunica albuginea replacement.

F. Giuliano, A. Durrbach, X. Qiu, 2012, The journal of sexual medicine.

Co-stimulation Blockade Plus T-Cell Depletion in Transplant Patients: Towards a Steroid- and Calcineurin Inhibitor-Free Future?

A. Durrbach, F. Herr, Mélanie Brunel, 2016, Drugs.

Targeting additional costimulatory pathways: a subtle role for CD2.

B. Charpentier, A. Durrbach, F. Hirsch, 2001, Transplantation proceedings.

Molecular basis for a novel systemic form of human hereditary apoA-I amyloidosis with vision loss

J. Straub, N. Rioux-Leclercq, F. Paraf, 2018, bioRxiv.

Characteristics of T- and NK-cell Lymphomas After Renal Transplantation: A French National Multicentric Cohort Study

P. Gaulard, G. Salles, P. Rieu, 2021, Transplantation.

Natural Killer Lymphocytes Are Dysfunctional in Kidney Transplant Recipients on Diagnosis of Cancer

P. Debré, S. Chevret, A. Toubert, 2015, Transplantation.

Natural Killer Lymphocytes Are Dysfunctional in Kidney Transplant Recipients On Diagnosis of Cancer.: Abstract# A17

A. Toubert, M. Venot, D. Glotz, 2014 .

Long‐term, prolonged‐release tacrolimus‐based immunosuppression in de novo kidney transplant recipients: 5‐year prospective follow‐up of the ADHERE study patients

F. Lehner, M. Christiaans, J. Klempnauer, 2019, Transplant international : official journal of the European Society for Organ Transplantation.

Methotrexate- and/or cytarabine-based chemotherapy may be effective and safe in solid-organ transplant recipients with primary central nervous system lymphomas

V. Ribrag, A. Durrbach, S. Pilorge, 2011, Leukemia & lymphoma.

An initial report from the French SOT COVID Registry suggests high mortality due to COVID-19 in recipients of kidney transplants

J. Dumortier, A. Heng, N. Kamar, 2020, Kidney International.

Risk Factors and Long‐Term Outcome of Transplant Renal Artery Stenosis in Adult Recipients After Treatment by Percutaneous Transluminal Angioplasty

P. Desgranges, H. Kobeiter, P. Grimbert, 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Candida albicans Arteritis Transmitted by Conservative Liquid After Renal Transplantation: A Report of Four Cases and Review of the Literature

D. Glotz, R. Snanoudj, B. Charpentier, 2006, Transplantation.

[Arterial anastomotic aneurysms after kidney and pancreas transplantation: diagnosis and management].

A. Durrbach, G. Benôit, P. Eschwege, 2013, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

De novo and recurrent diseases: recurrent glomerulopathies.

B. Charpentier, A. Durrbach, C. Hiesse, 1999, Transplantation proceedings.

Consequences of iliac arterial atheroma on renal transplantation.

B. Charpentier, A. Durrbach, G. Benôit, 2006, The Journal of urology.

20-Year Follow-Up Results of a Randomized Controlled Trial Comparing Antilymphocyte Globulin Induction to No Induction in Renal Transplant Patients

M. Ladouceur, B. Charpentier, A. Durrbach, 2008, Transplantation.

End-Stage Renal Disease-Associated Gut Bacterial Translocation: Evolution and Impact on Chronic Inflammation and Acute Rejection After Renal Transplantation

P. Rieu, J. Pais de Barros, A. Heng, 2019, Front. Immunol..

Surgical injuries occurring during kidney procurement performed by a renal transplantation team.

V. Paradis, P. Bedossa, J. Duranteau, 2002, Transplantation proceedings.

Usefulness of morphometric image analysis with Sirius Red to assess interstitial fibrosis after renal transplantation from uncontrolled circulatory death donors

H. François, A. Durrbach, C. Guettier, 2020, Scientific Reports.

Preoperative Risk Factors Associated With Urinary Complications After Kidney Transplantation.

H. François, A. Durrbach, D. Bedretdinova, 2017, Transplantation proceedings.

Acute respiratory failure in kidney transplant recipients: a multicenter study

B. Souweine, J. Timsit, A. Heng, 2011, Critical care.

Nonskeletal and skeletal effects of high doses versus low doses of vitamin D3 in renal transplant recipients: Results of the VITALE (VITamin D supplementation in renAL transplant recipients) study, a randomized clinical trial.

P. Rieu, E. Thervet, J. Souberbielle, 2023, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

High Dose Epoetin Beta in the First Weeks Following Renal Transplantation and Delayed Graft Function: Results of the Neo‐PDGF Study

L. Rostaing, G. Choukroun, N. Pallet, 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Prognostic significance of graft Foxp3 expression in renal transplant recipients: a critical review and attempt to reconcile discrepancies.

P. Grimbert, Y. Lebranchu, C. Baron, 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Population Pharmacokinetic Model of Plasma and Cellular Mycophenolic Acid in Kidney Transplant Patients from the CIMTRE Study

A. Durrbach, C. Verstuyft, V. Furlan, 2020, Drugs in R&D.

Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

Andrew J. Oler, Eglantine Ferrand Devouge, P. Gregersen, 2023, Genome Medicine.

Expanding the criteria of renal kidneys for transplantation: use of donors with acute renal failure.

L. Rostaing, N. Kamar, Benjamin Deroure, 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

First Nosocomial Outbreak of Vancomycin-Resistant Enterococcus faecium Expressing a VanD-Like Phenotype Associated with a vanA Genotype

P. Nordmann, T. Naas, R. Snanoudj, 2005, Journal of Clinical Microbiology.

Long‐term results of combined liver‐kidney transplantation for primary hyperoxaluria type 1: The French Experience

D. Samuel, K. Boudjema, L. Rostaing, 2014, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Immunosuppressive/ Regulatory T Cells Allograft Acceptance through Induction of Evidence to Support the Role of HLA-G5 in

N. Rouas-Freiss, E. Carosella, A. Durrbach, 2022 .

Impact of arteriovenous fistula cannulation on the quality of dialysis

S. Beaudreuil, B. Charpentier, A. Durrbach, 2018, Hemodialysis international. International Symposium on Home Hemodialysis.

Generation of a Novel Regulatory NK Cell Subset from Peripheral Blood CD34+ Progenitors Promoted by Membrane-Bound IL-15

S. Chouaib, S. Ferrini, S. Negrini, 2008, PloS one.

CD25 blockade in kidney transplant patients randomized to standard‐dose or high‐dose basiliximab with cyclosporine, or high‐dose basiliximab in a calcineurin inhibitor‐free regimen

L. Rostaing, G. Thibault, Y. Lebranchu, 2016, Transplant international : official journal of the European Society for Organ Transplantation.

Primary outcomes from a randomized, Phase III study of belatacept vs cyclosporine in ECD kidney transplants (BENEFIT-EXT Study)

Christian P. Larsen, Sander Florman, Y. Vanrenterghem, 2009 .

Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

Andrew J. Oler, Eglantine Ferrand Devouge, P. Gregersen, 2023, Genome Medicine.

Long‐term effects of calcineurin inhibitor conversion to mycophenolate mofetil on renal function after liver transplantation

D. Samuel, F. Saliba, B. Roche, 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Early, very high-titre convalescent plasma therapy in clinically vulnerable individuals with mild COVID-19 (COVIC-19): protocol for a randomised, open-label trial

E. Seifried, P. Tiberghien, G. Brunotte, 2023, BMJ Open.

Factors associated with Health-Related Quality of Life in Kidney Transplant Recipients in France

M. Alessandrini, E. Jouve, B. Dussol, 2018, BMC Nephrology.

Effect of coadministered HIV‐protease inhibitors on tacrolimus and sirolimus blood concentrations in a kidney transplant recipients

C. Créput, A. Durrbach, V. Furlan, 2009, Fundamental & clinical pharmacology.

Corynebacterium ulcerans in an Immunocompromised Patient with Diphtheria and Her Dog

P. Nordmann, P. Grimont, X. Monnet, 2005, Journal of Clinical Microbiology.

Comparison of 3 Estimation Methods of Mycophenolic Acid AUC based on a Limited Sampling Strategy in Renal Transplant Patients

P. Grimbert, P. Lang, A. Durrbach, 2009, Therapeutic drug monitoring.

Complement Inhibition Is Efficient in Early but Not Late Antibody-mediated Rejection After Kidney Transplantation

C. Suberbielle, H. François, S. Beaudreuil, 2018, International Journal of Renal Diseases and Therapy.

False-Negative Serum Protein Electrophoresis in a Sample with an IgM Monoclonal Protein by Semiautomated Gel Electrophoresis

A. Durrbach, M. Conti, P. Manivet, 2004 .

Circulating CASK is associated with recurrent focal segmental glomerulosclerosis after transplantation

Xiaomeng Zhang, A. Vazquez, F. Harper, 2019, PloS one.

Falsely elevated whole blood tacrolimus concentrations due to interference in an affinity column-mediated immunoassay method on Xpand dimension.

C. Frangié, A. Durrbach, C. Goujard, 2009, Therapeutic drug monitoring.

Race-free estimated glomerular filtration rate equation in kidney transplant recipients: development and validation study

Byron H. Smith, T. Larson, X. Jouven, 2023, BMJ.

New therapeutic targets for antibodies and recombinant proteins in organ transplantation.

Benjamin Deroure, C. Créput, B. Charpentier, 2007, Current opinion in molecular therapeutics.

Microchimerism in renal allografts: clinicopathological associations according to the type of chimeric cells

A. Durrbach, S. Romana, C. Guettier, 2010, Histopathology.

Outcomes at 3-Years in EBV+ Recipients of UNOS Criteria ECD Kidneys From a Randomized Trial (BENEFIT-EXT) Comparing Belatacept vs Cyclosporine.: Abstract# A202

B. Charpentier, A. Durrbach, C. Jones-Burton, 2014 .

T-cell phenotype in protocol renal biopsy from transplant recipients treated with belatacept-mediated co-stimulatory blockade.

P. Grimbert, P. Lang, A. Durrbach, 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

OUTCOMES AS A FUNCTION OF DONOR CRITERIA FROM A PHASE III STUDY OF BELATACEPT VS CYCLOSPORINE IN KIDNEY TRANSPLANTATION (BENEFIT-EXT): 1773

Y. Vanrenterghem, F. Vincenti, C. Larsen, 2010 .

CO-STIMULATION BLOCKADE WITH LEA29Y IN A CALCINEURIN INHIBITOR FREE MAINTENANCE REGIMEN IN RENAL TRANSPLANT: 6-MONTH EFFICACY AND SAFETY

P. Halloran, B. Nashan, P. Lang, 2004 .

mTOR Inhibition Impairs the Activation and Function of Belatacept-Resistant CD4+CD57+ T Cells In Vivo and In Vitro

E. Fadel, A. Durrbach, C. Desterke, 2023, Pharmaceutics.

Clinical Utility of Biochemical Markers for the Prediction of COVID-19−Related Mortality in Kidney Transplant Recipients

J. Dumortier, A. Heng, N. Kamar, 2021, Kidney International Reports.

Antibody-mediated endocytosis of G250 tumor-associated antigen allows targeted gene transfer to human renal cell carcinoma in vitro

A. Dürrbach, B. Charpentier, A. Durrbach, 1999, Cancer Gene Therapy.

[Occurrence of extracapillary glomerulonephritis during Mediterranean boutonneuse fever].

A. Durrbach, P. Callard, A. Jaccard, 1996, Nephrologie.